What My Mother Taught Me About Digital Health
Michael Greenberg, Vice President, Regional Medical Head, North America at Sanofi Pasteur, reflects on telehealth’s potential in the pharmaceutical industry and across the health system.
Inside Sanofi’s Hemophilia Research
Sanofi scientists are expanding the therapeutic possibilities for hemophilia patients through continuous discovery and innovation. Their goal is to give families with hemophilia more choices for treatment.
Clinical Trials Can Make Anyone a Hero
Raolat Abdulai, MD, Clinical Research Director, shares how she made the choice that made her a hero – although she never expected to be one.
For Sanofi Scientist Amy Richards, Research Is Personal
Amy Richards is a researcher at Sanofi’s lab in Framingham, Mass., focusing on rare neurodegenerative diseases. Amy is part of a team of scientists working on the GBA-related Parkinson’s disease project, a rare form of the chronic neuro-degenerative condition.
Making Strides in Immunology and Inflammation Research
Naimish Patel, MD, leads the development of one of our research areas in Immunology and Inflammation. Here he discusses his training and work as a pulmonologist and how that impacts the work that he does at Sanofi every day.
Meet Sanofi’s R&D Postdoctoral Program
Three of Sanofi R&D’s Postdoctoral Fellows share their unique experience coming to work in Sanofi’s labs alongside our seasoned scientists to explore science and technology.
Using Real World Evidence to Drive Outcomes in Diabetes Care
A pioneer in using real world evidence and large-scale data, Rachele Berria, MD, PhD, Head of US Diabetes Medical Affairs, is determined to help improve health outcomes for people living with diabetes.
Looking to the Future in Cardiovascular Treatment
More than 10 years of experience in lipid management prepared Jeremy Smart, PharmD, BCPS, CLS for his role at Sanofi as a Medical Liaison for the cardiovascular team.
New Sanofi HIV Research
"I am delighted that a newly-published article in the journal Science highlights our early-stage research into “trispecific” antibodies as a potential new paradigm for combating HIV.”
Science is Our Passion: Leila
Leila Sevigny, PhD, is a senior scientist in Biologics Research at Sanofi’s lab in Framingham, Mass., where she specializes in Antibody Development and Protein Production. Find out what inspires her.
VR Brings Immunotherapy to Life
Several scientists from the Sanofi North America R&D Hub were recently featured in the Pharmaceutical Research and Manufacturers of America (PhRMA) GoBoldly national campaign.